JP2012115277A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012115277A5 JP2012115277A5 JP2012020504A JP2012020504A JP2012115277A5 JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5 JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- polypeptide according
- yrkyrkryyyrkyrkryy
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 208000036142 Viral infection Diseases 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101150037123 APOE gene Proteins 0.000 claims 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0329254.7A GB0329254D0 (en) | 2003-12-17 | 2003-12-17 | Treatment of viral infections |
| GB0329254.7 | 2003-12-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Division JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012115277A JP2012115277A (ja) | 2012-06-21 |
| JP2012115277A5 true JP2012115277A5 (enExample) | 2013-06-27 |
Family
ID=30471239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Pending JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
| JP2012020504A Pending JP2012115277A (ja) | 2003-12-17 | 2012-02-02 | ウイルス感染の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Pending JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7691382B2 (enExample) |
| EP (2) | EP1709075B9 (enExample) |
| JP (2) | JP2007535910A (enExample) |
| CN (2) | CN1894281B (enExample) |
| AU (1) | AU2004299343B8 (enExample) |
| CA (1) | CA2548585A1 (enExample) |
| DK (1) | DK1709075T3 (enExample) |
| ES (1) | ES2389078T3 (enExample) |
| GB (1) | GB0329254D0 (enExample) |
| PL (1) | PL1709075T3 (enExample) |
| WO (1) | WO2005058959A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
| GB0329958D0 (en) | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
| GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
| GB0513096D0 (en) * | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
| EP1937815B1 (en) * | 2005-09-13 | 2015-05-13 | National Research Council of Canada | Methods and compositions for modulating tumor cell activity |
| EP2085774B1 (en) * | 2008-02-01 | 2018-04-11 | Kraft Foods R & D, Inc. | Method for determining the texture of food material |
| WO2009102715A2 (en) * | 2008-02-11 | 2009-08-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Peptide therapy for ocular herpes infections |
| US8618247B2 (en) * | 2008-02-14 | 2013-12-31 | Enplas Corporation | Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| PT2504363T (pt) | 2009-11-24 | 2019-08-02 | Nat Res Council Canada | Anticorpos anticlusterina e fragmentos de ligação ao antigénio e a sua utilização para reduzir o volume de um tumor |
| US20120053128A1 (en) * | 2010-08-26 | 2012-03-01 | Xavier University | Method of inhibiting angiogenesis |
| WO2013013187A1 (en) | 2011-07-21 | 2013-01-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Apolipoprotein e polypeptides and their use |
| CA2862739A1 (en) | 2012-02-22 | 2013-08-29 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| WO2013148305A1 (en) * | 2012-03-29 | 2013-10-03 | Xavier University Of Louisiana | Method for treating diabetic retinopathy |
| WO2016054250A1 (en) * | 2014-10-01 | 2016-04-07 | Cascadia Life Sciences Llc | Anti-viral peptides |
| WO2016054310A1 (en) | 2014-10-01 | 2016-04-07 | Plant Health Care, Inc. | Hypersensitive response elicitor peptides and use thereof |
| JP2017532981A (ja) | 2014-10-01 | 2017-11-09 | プラント ヘルス ケア インコーポレイテッド | 破壊された過敏感反応ボックスを有するエリシターペプチド及びその使用 |
| WO2017176588A1 (en) | 2016-04-06 | 2017-10-12 | Plant Health Care, Inc. | Beneficial microbes for delivery of effector peptides or proteins and use thereof |
| ES3039620T3 (en) | 2016-04-06 | 2025-10-23 | Plant Health Care Inc | Hypersensitive response elicitor-derived peptides and use thereof |
| WO2020223581A1 (en) * | 2019-04-30 | 2020-11-05 | Maxwell Biosciences, Inc. | Halogenated antimicrobial peptoids |
| CN116813712B (zh) * | 2023-06-16 | 2024-03-29 | 东北农业大学 | 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5473039A (en) * | 1989-08-18 | 1995-12-05 | The Scripps Research Institute | Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs |
| WO1993000443A1 (en) * | 1991-06-26 | 1993-01-07 | Bio-Technology General Corp. | Purification of recombinant apolipoprotein e from bacteria |
| US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
| JP2001518449A (ja) * | 1997-09-30 | 2001-10-16 | デューク・ユニバーシティー | アポリポタンパク質ｅ／成長因子複合体およびその使用法 |
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| GB0200757D0 (en) * | 2002-01-15 | 2002-02-27 | Univ Manchester | Diagnostic methods |
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
-
2003
- 2003-12-17 GB GBGB0329254.7A patent/GB0329254D0/en not_active Ceased
-
2004
- 2004-12-17 CN CN2004800379084A patent/CN1894281B/zh not_active Expired - Fee Related
- 2004-12-17 ES ES04806160T patent/ES2389078T3/es not_active Expired - Lifetime
- 2004-12-17 PL PL04806160T patent/PL1709075T3/pl unknown
- 2004-12-17 EP EP04806160A patent/EP1709075B9/en not_active Expired - Lifetime
- 2004-12-17 CA CA002548585A patent/CA2548585A1/en not_active Abandoned
- 2004-12-17 JP JP2006544559A patent/JP2007535910A/ja active Pending
- 2004-12-17 WO PCT/GB2004/005360 patent/WO2005058959A2/en not_active Ceased
- 2004-12-17 EP EP10010764A patent/EP2277911A1/en not_active Withdrawn
- 2004-12-17 CN CN2011102495236A patent/CN102336815A/zh active Pending
- 2004-12-17 US US10/580,761 patent/US7691382B2/en active Active
- 2004-12-17 AU AU2004299343A patent/AU2004299343B8/en not_active Ceased
- 2004-12-17 DK DK04806160.0T patent/DK1709075T3/da active
-
2010
- 2010-02-09 US US12/702,919 patent/US20100221273A1/en not_active Abandoned
-
2012
- 2012-02-02 JP JP2012020504A patent/JP2012115277A/ja active Pending
- 2012-07-16 US US13/550,029 patent/US20130150288A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012115277A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| JP2012082206A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2011528896A5 (enExample) | ||
| JP2016509011A5 (enExample) | ||
| JP2013520405A5 (enExample) | ||
| JP2012176978A5 (enExample) | ||
| JP2015522576A5 (enExample) | ||
| JP2011528901A5 (enExample) | ||
| JP2010227101A5 (enExample) | ||
| RU2015119517A (ru) | Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1 | |
| JP2012529293A5 (enExample) | ||
| JP2011528895A5 (enExample) | ||
| JP2015514132A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2015533791A5 (enExample) | ||
| JP2007535910A5 (enExample) | ||
| JP2010508030A5 (enExample) | ||
| JP2015520178A5 (enExample) | ||
| JP2011528897A5 (enExample) | ||
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| JP2019513752A5 (enExample) | ||
| JP2015521206A5 (enExample) |